INSIDER TRADING

MAIA Biotechnology, Inc. director Stan Smith buys 100,000 shares worth $100,000

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
MAIA Biotechnology, Inc. director Stan Smith buys 100,000 shares worth $100,000

An open-market purchase between Nov 13 and Nov 16, reported to the SEC on Nov 17. Information only, not investment advice.

Insider buying at MAIA Biotechnology, Inc.: Stan Smith, a director, added 100,000 shares between Nov 13 and Nov 16 for about $100,000, at an average of $1.00 a share, a Form 4 filed on Nov 17 shows.

The filing reports the shares as held indirectly, for example through a trust or a fund. The trade was reported within two business days, as Section 16 requires.

After the trade, the filing lists 1,619,178 shares held. It is the seventh insider purchase at MAIA Biotechnology, Inc. reported in the last 90 days.

The numbers below are taken from the Form 4 as filed with the SEC.

The purchase
CompanyMAIA Biotechnology, Inc. (MAIA)
InsiderStan Smith
RoleDirector
TransactionOpen-market purchase (code P)
Shares100,000
Average price$1.00
Value$100,000
Trade datesNov 13 to Nov 16, 2026
Filed with the SECNov 17, 2026, 4:07 PM ET
Shares held after1,619,178
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

View the Form 4 on SEC.gov

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.